These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28677007)

  • 1. Modeling human disease in rodents by CRISPR/Cas9 genome editing.
    Birling MC; Herault Y; Pavlovic G
    Mamm Genome; 2017 Aug; 28(7-8):291-301. PubMed ID: 28677007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research.
    Zhang J; Khazalwa EM; Abkallo HM; Zhou Y; Nie X; Ruan J; Zhao C; Wang J; Xu J; Li X; Zhao S; Zuo E; Steinaa L; Xie S
    J Genet Genomics; 2021 May; 48(5):347-360. PubMed ID: 34144928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 disease models in zebrafish and Xenopus: The genetic renaissance of fish and frogs.
    Naert T; Vleminckx K
    Drug Discov Today Technol; 2018 Aug; 28():41-52. PubMed ID: 30205880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaicism in CRISPR/Cas9-mediated genome editing.
    Mehravar M; Shirazi A; Nazari M; Banan M
    Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Identify Genetic Variants Causing Infertility.
    Ding X; Schimenti JC
    Trends Mol Med; 2021 Aug; 27(8):792-806. PubMed ID: 33431240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9: A cornerstone for the evolution of precision medicine.
    Razzouk S
    Ann Hum Genet; 2018 Nov; 82(6):331-357. PubMed ID: 30014471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.
    Barazesh M; Mohammadi S; Bahrami Y; Mokarram P; Morowvat MH; Saidijam M; Karimipoor M; Kavousipour S; Vosoughi AR; Khanaki K
    Curr Gene Ther; 2021; 21(2):130-148. PubMed ID: 33319680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9.
    Zarei A; Razban V; Hosseini SE; Tabei SMB
    J Gene Med; 2019 Apr; 21(4):e3082. PubMed ID: 30786106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing the genome of hiPSC with CRISPR/Cas9: disease models.
    Bassett AR
    Mamm Genome; 2017 Aug; 28(7-8):348-364. PubMed ID: 28303292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
    Sarkar E; Khan A
    Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.